qrx-3
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
2
Phase 4
0
Earliest trial started Mar 1, 2023 (NCT06948292)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06866236 | Phase 2/Phase 3 (Phase 3) | Oct 31, 2025 | Neukidney Inc. |
| NCT07161843 | Phase 2/Phase 3 (Phase 3) | Aug 30, 2025 | Neukidney Inc. |
| NCT06948292 | Phase 2 | Mar 1, 2023 | Neukidney Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Neukidney Inc. | For profit | 3 | 3 | 2 | 2023 |
1 organizations
Page 1 / 1